Medical Device Network on MSN
Cleveland Diagnostics’ IsoPSA secures FDA approval for prostate cancer
The decision is supported by evidence from a clinical study and data from supporting analytical validation trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback